These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 17376993)

  • 41. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease.
    Chao YX; He BP; Tay SS
    J Neuroimmunol; 2009 Nov; 216(1-2):39-50. PubMed ID: 19819031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lesion of the locus coeruleus aggravates dopaminergic neuron degeneration by modulating microglial function in mouse models of Parkinson׳s disease.
    Yao N; Wu Y; Zhou Y; Ju L; Liu Y; Ju R; Duan D; Xu Q
    Brain Res; 2015 Nov; 1625():255-74. PubMed ID: 26342895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors.
    Villar-Cheda B; Dominguez-Meijide A; Joglar B; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
    Neurobiol Dis; 2012 Aug; 47(2):268-79. PubMed ID: 22542954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of Nur77 in microglia attenuates proinflammatory mediators production and protects dopaminergic neurons from inflammation-induced cell death.
    Liu TY; Yang XY; Zheng LT; Wang GH; Zhen XC
    J Neurochem; 2017 Feb; 140(4):589-604. PubMed ID: 27889907
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease.
    Duan W; Mattson MP
    J Neurosci Res; 1999 Jul; 57(2):195-206. PubMed ID: 10398297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel role of aquaporin-4 in CD4+ CD25+ T regulatory cell development and severity of Parkinson's disease.
    Chi Y; Fan Y; He L; Liu W; Wen X; Zhou S; Wang X; Zhang C; Kong H; Sonoda L; Tripathi P; Li CJ; Yu MS; Su C; Hu G
    Aging Cell; 2011 Jun; 10(3):368-82. PubMed ID: 21255222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
    Kubo K; Inada T; Shingu K
    Brain Res; 2011 Apr; 1387():125-33. PubMed ID: 21376018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preventive role of PD-1 on MPTP-induced dopamine depletion in mice.
    Jung HW; Son HY; Jin GZ; Park YK
    Cell Biochem Funct; 2010 Apr; 28(3):217-23. PubMed ID: 20186864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
    Kim S; Moon M; Park S
    J Endocrinol; 2009 Sep; 202(3):431-9. PubMed ID: 19570816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease.
    Shavali S; Combs CK; Ebadi M
    Neurochem Res; 2006 Jan; 31(1):85-94. PubMed ID: 16475001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
    Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
    Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pain perception in acute model mice of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Park J; Lim CS; Seo H; Park CA; Zhuo M; Kaang BK; Lee K
    Mol Pain; 2015 May; 11():28. PubMed ID: 25981600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease.
    Virgone-Carlotta A; Uhlrich J; Akram MN; Ressnikoff D; Chrétien F; Domenget C; Gherardi R; Despars G; Jurdic P; Honnorat J; Nataf S; Touret M
    Glia; 2013 Oct; 61(10):1645-58. PubMed ID: 23893349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress.
    Mori S; Sugama S; Nguyen W; Michel T; Sanna MG; Sanchez-Alavez M; Cintron-Colon R; Moroncini G; Kakinuma Y; Maher P; Conti B
    J Neuroinflammation; 2017 Apr; 14(1):88. PubMed ID: 28427412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
    Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
    Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity.
    McLaughlin P; Zhou Y; Ma T; Liu J; Zhang W; Hong JS; Kovacs M; Zhang J
    Glia; 2006 Apr; 53(6):567-82. PubMed ID: 16419087
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
    Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
    Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L
    Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease.
    Zhang W; Phillips K; Wielgus AR; Liu J; Albertini A; Zucca FA; Faust R; Qian SY; Miller DS; Chignell CF; Wilson B; Jackson-Lewis V; Przedborski S; Joset D; Loike J; Hong JS; Sulzer D; Zecca L
    Neurotox Res; 2011 Jan; 19(1):63-72. PubMed ID: 19957214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TLR9 activation via microglial glucocorticoid receptors contributes to degeneration of midbrain dopamine neurons.
    Maatouk L; Compagnion AC; Sauvage MC; Bemelmans AP; Leclere-Turbant S; Cirotteau V; Tohme M; Beke A; Trichet M; Bazin V; Trawick BN; Ransohoff RM; Tronche F; Manoury B; Vyas S
    Nat Commun; 2018 Jun; 9(1):2450. PubMed ID: 29934589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.